Phase 2 Carcinoma, Renal Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Carcinoma, Renal Cell
Oncorena AB75 enrolled5 locationsNCT05287945
Recruiting
Phase 1Phase 2
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Metastatic Renal Cell CarcinomaCarcinoma, Renal CellAdvanced Renal Cell Carcinoma+8 more
Pfizer224 enrolled49 locationsNCT07227415
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC
Carcinoma, Renal Cell
State University of New York at Buffalo28 enrolled1 locationNCT06222593
Recruiting
Phase 2
Autologous Dendritic Cell Vaccine in Kidney Cancer
Carcinoma, Renal Cell
Jodi Maranchie42 enrolled1 locationNCT05127824
Recruiting
Phase 2
A Study of Oncobax®-AK in Patients With Advanced Solid Tumors
Carcinoma, Renal Cell
EverImmune122 enrolled4 locationsNCT05865730